The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity
Open accessAbstract
Tissue fibrosis is a key driver of end-stage organ failure and cancer, overall accounting for up to 45% of deaths in developed countries. There is a large unmet medical need for antifibrotic therapies. Claudin-1 (CLDN1) is a member of the tight junction protein family. Although the role of CLDN1 incorporated in tight junctions is well established, the function of nonjunctional CLDN1 (njCLDN1) is largely unknown. Using highly specific monoclonal antibodies targeting a conformation-dependent epitope of exposed njCLDN1, we show in patient-derived liver three-dimensional fibrosis and human liver chimeric mouse models that CLDN1 is a mediator and target for liver fibrosis. Targeting CLDN1 reverted inflammation-induced hepatocyte profibrogenic signaling and cell fate and suppressed the myofibroblast differentiation of hepatic stellate cells. Safety studies of a fully humanized antibody in nonhuman primates did not reveal any serious adverse events even at high steady-state concentrations. Our results provide preclinical proof of concept for CLDN1-specific monoclonal antibodies for the treatment of advanced liver fibrosis and cancer prevention. Antifibrotic effects in lung and kidney fibrosis models further indicate a role of CLDN1 as a therapeutic target for tissue fibrosis across organs. In conclusion, our data pave the way for further therapeutic exploration of CLDN1-targeting therapies for fibrotic diseases in patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
1 retracted
Suh, Y., Yoon, C.-H., Kim, R.-K., Lim, E.-J., Oh, Y. S., Hwang, S.-G., An, S., Yoon, G., Gye, M. C., Yi, J.-M., et al. (2013) · Oncogene · doi:10.1038/onc.2012.505 · Cited by 230
RetractedAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Comparison of simple potential functions for simulating liquid water
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983) · The Journal of Chemical Physics · doi:10.1063/1.445869 · Cited by 41,298
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Research works printed but not linked: 3
- K. J. Bowers E. Chow H. Xu R. O. Dror M. P. Eastwood B. A. Gregersen J. L. Klepeis I. Kolossvary M. A. Moraes F. D. Sacerdoti J. K. Salmon Y. Shan D. E. Shaw paper presented at the Proceedings of the 2006 ACM/IEEE conference on Supercomputing Tampa Florida 11 to 17 November 2006.
- F. Ambrosetti S. Jandova A. M. Bonvin A protocol for information-driven antibody-antigen modelling with the HADDOCK2.4 webserver. arXiv:2005.03283 [q-bio.BM] (7 May 2020). · arXiv
- 10.1016/j.cell.2021.04.048 · doi:10.1016/j.cell.2021.04.048 · Paper page
Cited by
ECM formation and degradation during fibrosis, repair, and regeneration
Mayorca-Guiliani, A. E., Leeming, D. J., Henriksen, K., Mortensen, J. H., Nielsen, S. H., Anstee, Q. M., Sanyal, A. J., Karsdal, M. A., & Schuppan, D. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00063-4 · Cited by 176
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
“Interesting recent work has demonstrated a potent antifibrotic, proregenerative effect of inhibiting the claudin-1 receptor through its effects not only on hepatocytes but also in HSCs (314).”
BackgroundTight Junction Protein Signaling and Cancer Biology
Nehme, Z., Roehlen, N., Dhawan, P., & Baumert, T. F. (2023) · Cells · doi:10.3390/cells12020243 · Cited by 94
Self-citationTargeting the liver clock improves fibrosis by restoring TGF-β signaling
Crouchet, É., Dachraoui, M., Jühling, F., Roehlen, N., Oudot, M. A., Durand, S., Ponsolles, C., Gadenne, C., Heydmann, L., Moehlin, J., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.07.034 · Cited by 73
Self-citationClaudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer
Primeaux, M., Liu, X., Gowrikumar, S., Fatima, I., Fisher, K. W., Bastola, D. K., Vecchio, A. J., Singh, A. B., & Dhawan, P. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216479 · Cited by 61
Metadata
- Authors
- Roehlen, N., Saviano, A., El Saghire, H., Crouchet, E., Nehme, Z., Del Zompo, F., Jühling, F., Oudot, M. A., Durand, S. C., Duong, F. H. T., Cherradi, S., Gonzalez Motos, V., Almeida, N., Ponsolles, C., Heydmann, L., Ostyn, T., Lallement, A., Pessaux, P., Felli, E., Cavalli, A., Sgrignani, J., Thumann, C., Koutsopoulos, O., Fuchs, B. C., Hoshida, Y., Hofmann, M., Vyberg, M., Viuff, B. M., Galsgaard, E. D., Elson, G., Toso, A., Meyer, M., Iacone, R., Schweighoffer, T., Teixeira, G., Moll, S., De Vito, C., Roskams, T., Davidson, I., Heide, D., Heikenwälder, M., Zeisel, M. B., Lupberger, J., Mailly, L., Schuster, C., & Baumert, T. F.
- Affiliations
- Inserm (FR)
- Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR-S1110, 67000 Strasbourg, France.
- KU Leuven (BE)
- Centre National de la Recherche Scientifique (FR)
- Institute for Research in Biomedicine (CH)
- Harvard University (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- University of Freiburg (DE)
- Hvidovre Hospital (DK)
- Novo Nordisk (Denmark) (DK)
- Alentis Therapeutics, 4123 Allschwil, Switzerland.
- University Hospital of Geneva (CH)
- Department of Pathology, University Hospital of Geneva, 1205 Geneva, Switzerland.
- German Cancer Research Center (DE)
- Corresponding author
- Roehlen, Natascha
- Saviano, Antonio
- Baumert, Thomas F.
- ORCID
- Roehlen, Natascha
- Saviano, Antonio
- Nehme, Zeina
- Del Zompo, Fabio
- Jühling, Frank
- Oudot, Marine A.
- Duong, François H. T.
- Cherradi, Sara
- Gonzalez Motos, Victor
- Almeida, Nuno
- Ponsolles, Clara
- Heydmann, Laura
- Ostyn, Tessa
- Lallement, Antonin
- Pessaux, Patrick
- Felli, Emanuele
- Cavalli, Andrea
- Sgrignani, Jacopo
- Thumann, Christine
- Fuchs, Bryan C.
- Hoshida, Yujin
- Hofmann, Maike
- Vyberg, Mogens
- Viuff, Birgitte Martine
- Galsgaard, Elisabeth D.
- Toso, Alberto
- Meyer, Markus
- Schweighoffer, Tamas
- Moll, Solange
- De Vito, Claudio
- Roskams, Tania
- Davidson, Irwin
- Heide, Danijela
- Heikenwälder, Mathias
- Zeisel, Mirjam B.
- Lupberger, Joachim
- Mailly, Laurent
- Schuster, Catherine
- Baumert, Thomas F.
- Venue
- Science Translational Medicine
- Published
- 2022-12-21
- Volume
- 14
- Issue
- 676
- Pages
- eabj4221-eabj4221
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W4312115066
- Cited by
- 54
- References
- 92
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 16 · 2023: 4
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- green
- vbn.aau.dk
- Licence
- cc-by-nc
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- VBN Forskningsportal (Aalborg Universitet) (publishedVersion, cc-by-nc)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- HAL (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- European Commission (101021417, ERC-AdG-2014, #671231, 667273, H2020, #862551)
- Deutsche Forschungsgemeinschaft (RO 5983/1-1, SFB-1479 –)
- Agence Nationale de la Recherche (ANR-21-RHUS-0001, ANR-10, ANR-10-LABX-0028)
- Université de Strasbourg
- KU Leuven
- Fondation ARC pour la Recherche sur le Cancer
- Novo Nordisk Fonden (NNF18OC0033438)
- Société d'Accélération du Transfert de Technologies
- Horizon 2020 Framework Programme (667273)
- H2020 European Research Council (683000)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- claudin-1, liver fibrosis, antifibrotic therapy, monoclonal antibodies, tight junction proteins, myofibroblast differentiation, hepatic stellate cells, pulmonary fibrosis, renal fibrosis, cancer prevention
- MeSH terms
- Cell Plasticity, Animals, Antibodies, Monoclonal, Humans, Liver Cirrhosis, Mice, Claudin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity. https://app.cochat.ai/papers/10.1126/scitranslmed.abj4221
- The paper
- Roehlen, N., Saviano, A., El Saghire, H., Crouchet, E., Nehme, Z., Del Zompo, F., Jühling, F., Oudot, M. A., Durand, S. C., Duong, F. H. T., Cherradi, S., Gonzalez Motos, V., Almeida, N., Ponsolles, C., Heydmann, L., Ostyn, T., Lallement, A., Pessaux, P., Felli, E., . . . Baumert, T. F. (2022). A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abj4221
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.